Get the Stockscreener App
78.18
0.95%
-0.75
After Hours:
77.30
-0.88
-1.13%
Livanova Plc stock is traded at $78.18, with a volume of 425.88K.
It is down -0.95% in the last 24 hours and up +2.22% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$78.93
Open:
$78.11
24h Volume:
425.88K
Relative Volume:
0.61
Market Cap:
$4.31B
Revenue:
$1.43B
Net Income/Loss:
$107.13M
P/E Ratio:
40.36
EPS:
1.9372
Net Cash Flow:
$161.04M
1W Performance:
-3.72%
1M Performance:
+2.22%
6M Performance:
+26.24%
1Y Performance:
+38.32%
1-Day Range:
$77.37
$78.88
1-Week Range:
$77.37
$82.22
52-Week Range:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.18 | 4.35B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
LivaNova Director Sells 1,650 Shares for $131,500 - The Motley Fool
LivaNova (NASDAQ: LIVN) officer plans 3,500-share sale from 2026 stock award vesting - Stock Titan
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setup - ChartMill
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - Stock Titan
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - Stock Titan
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - Yahoo Finance
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - ad-hoc-news.de
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - Stock Titan
LivaNova PLC (LIVN) director sells 1,650 shares - Stock Titan
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - ad-hoc-news.de
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - Sahm
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionEarnings Manipulation Risk - vinanet.vn
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) Q2 2026 Earnings Call Transcript - AOL.com
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
LivaNova (LIVN) executive exercises 12,692 SARs and disposes shares - Stock Titan
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN) - Yahoo Finance
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance - Yahoo Finance
LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale - Stock Titan
LivaNova PLC (LIVN) Stock Forecasts - Yahoo! Finance Canada
LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026What's Changed - webull.com
LivaNova Plans for Early 2027 Launch of Aura6000 for Obstructive Sleep Apnea - Morningstar
LivaNova PLC at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Q3 2025 LivaNova PLC Earnings Call Transcript - GuruFocus
Q1 2026 LivaNova PLC Earnings Call Transcript - GuruFocus
LivaNova PLC $LIVN Shares Purchased by Quantinno Capital Management LP - MarketBeat
Price to earnings forward of LivaNova Plc – FWB:LIA - TradingView
LivaNova revenue increases 10.8% in Q2 2026 - medicalbuyer.co.in
LivaNova PLC (LIVN) Stock News Today - TradingKey
LivaNova PLC (LIA) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
LivaNova PLC (LIA) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):